Event info
Date:25 Oct
Time:14.30 - 18.00
Venue:Medicon Village, Lund
Contact person
Sofia Norås

Sofia Norås

Project Manager

sn@mva.org

+45 2337 0040

MVA R&D Network – Preparing for the next pandemic; Focusing on infectious disease

Medicon Valley Alliance, together with member organisations Iconovo and Medicon Village, have the pleasure to invite you to the Medicon Valley Alliance R&D Network meeting with the theme: Preparing for the next pandemic – focusing on infectious disease on 25th of October.

The emergence and spread of infectious diseases and global pandemics have occurred regularly in the past, and new pandemics will arise in the future. An important lesson learned from the latest Covid-19 pandemic is that rapidly learning from and responding to an emerging infectious disease outbreak, through the help of innovative diagnostic and treatment methods, is crucial for saving health and lives.

In this MVA R&D network meeting we would like to invite you to hear from speakers from industry and academia who will share their methods, latest developments and insights emerging from their experiences with the Covid-19 pandemic. These Medicon Valley-based companies and organisations will share how they responded, innovated and developed platforms and technologies that would enable society to be future ready when it comes to the next pandemic.

Date: 25th of October
Time: 14.30 – 18.30
Venue: Medicon Village, Allvar, Building Inspira, Scheelevägen 4, Lund
Hosts: Iconovo and Medicon Village

 

SIGN UP

 

PROGRAM: 

14.30 – 15.00Registration, networking and refreshments
15.00 – 15.10Welcome 
Anette Steenberg, CEO, Medicon Valley Alliance
Johan Wäborg, CEO, Iconovo
Petter Hartman, CEO, Medicon Village
15.10 – 15.15Protecting inventions in a high-speed pandemic environment
Peter Holm, Partner European Patent Attorney, Høiberg
15.15 – 15.30ICOone® Nasal – Novel system for combined nasal and pulmonary drug delivery
Orest Lastow, Ph.D, Founder and CTO, Iconovo
15.30 – 15.45ISR52 a nasally inhaled dry-powder vaccine – suggests a better protection from IgA response in the nasal mucosa
Nigel Goodman, Cheif of Clinical Operations, ISR Immune System Regulation
15.45 – 16.00Is antimicrobial resistance the next pandemic? Gedea finds ways to treat infection without using antibiotics
Helena Strevens, Associate Professor, Dep of Obstetrics and Gynecology , Skåne University Hospital & Founder and Medical Director at Gedea Biotech
16.00- 16.30Break and networking
16.30- 16.45
Panviral: Creating the diagnostic platform of tomorrow
Jack Egelund Madsen, CEO, Diagonal Bio
16.45 – 17.00Predicting T cell responses. Key learnings from SARS-CoV2 to prepare for the next pandemic
Stephan Thorgrimsen, CEO, Immunitrack
17.00 – 17.15COVID-19 test capacity during the pandemic –  the role of Centre for Diagnostics at DTU
Helene Larsen, Head of Center, Center for Diagnostics, DTU Health Technology
17.15 – 17.30Q&A and concluding remarks
17.30 – 18.30  
Networking
  

 

Deadline for registration is 20th of October. 

For more information please contact Sofia Norås sn@mva.org

The MVA R&D Network
The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The network focuses on sharing best practice and experiences, as well as discussing current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region, such as how we can strengthen collaboration and knowledge-sharing between academia and industry to stimulate start-up, scale-up, commercialization and growth and wat is required to turn great science into successful innovations.

Joining the network is free of charge but is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate the relevance in joining the network. For more information please contact Sofia Norås sn@mva.org

  
Hosts: Sponsor of event: 
  
MVA R&D Network is managed by: In collboration with: